Activation of hepatocyte growth factor-met autocrine loop enhances tumorigenicity in a human lung adenocarcinoma cell line.
about
The MET axis as a therapeutic target.Biomarker development in MET-targeted therapyPrognostic value of c-Met in colorectal cancer: a meta-analysisCo-overexpression of Met and hepatocyte growth factor promotes systemic metastasis in NCI-H460 non-small cell lung carcinoma cells.C-Met as a prognostic marker in gastric cancer: a systematic review and meta-analysis.Clinical significance of hepatocyte growth factor/c-Met expression in the assessment of gastric cancer progression.The hepatocyte growth factor/c-Met signaling pathway as a therapeutic target to inhibit angiogenesis.MET as a possible target for non-small-cell lung cancer.c-Met and hepatocyte growth factor: potential as novel targets in cancer therapy.Modulation of c-Met signaling and cellular sensitivity to radiation: potential implications for therapyMET as a target for treatment of chest tumorsc-MET as a potential therapeutic target and biomarker in cancer.Personalized Radiation Oncology: Epidermal Growth Factor Receptor and Other Receptor Tyrosine Kinase Inhibitors.Diagnosis and Molecular Classification of Lung Cancer.Analysis of HGF, MACC1, C-met and apoptosis-related genes in cervical carcinoma mice.The c-Met receptor: Implication for targeted therapies in colorectal cancer.Involvement of HGF/SF-Met signaling in prostate adenocarcinoma cells: evidence for alternative mechanisms leading to a metastatic phenotype in Pr-14c.Constitutive activation of met kinase in non-small-cell lung carcinomas correlates with anchorage-independent cell survival.A two-way interaction between hepatocyte growth factor and interleukin-6 in tissue invasion of lung cancer cell line.Inhibition of human non-small cell lung tumors by a c-Met antisense/U6 expression plasmid strategy.Mechanisms of receptor tyrosine kinase activation in cancer.Beyond EGFR and ALK: targeting rare mutations in advanced non-small cell lung cancer.
P2860
Q24609682-5F605C91-DA17-418C-9481-7B729145EADFQ26751332-C3383B7C-A58B-4EF4-B7A2-F7566701EE79Q26860232-936300AE-C541-49ED-904F-0B12A16E819FQ30492361-7163FACE-09F2-40BE-9E26-F4FA33D0B1B8Q35041171-77CA1780-F475-4CDD-B685-7A30224544F7Q35201636-B088739D-61C6-437E-B340-6420B517C67BQ35563524-B4A23083-B11F-4073-8839-58D40F63D8ACQ36660673-656EB9B1-63CF-45A7-B574-0C8D9E3C51DAQ36731520-ADB23CF1-6586-40AD-AEB2-46016F108205Q36828371-59650399-1328-44EF-8EC7-20D82D0ABEAAQ37232416-CE67C3F8-77A6-41CB-BF58-9CCC951E2295Q37962905-7178FFE9-0DB2-4BD4-AEF0-734CF218B65EQ38869428-D224DB87-6381-4055-9548-949D122C6C8BQ38930336-821395A7-FB82-4F16-8174-5D32B63FD16DQ39029873-27C8942A-C5B6-4B24-9F4D-38D965C67882Q39274990-62F4FB7C-44BF-4109-8CBB-86AC49DF5257Q40464303-800CE387-EA13-4835-B018-1BC00FA7CC7DQ40706645-33C72025-99A1-440A-B12D-C4EA399A2DFEQ40714043-CFC901E6-7439-4A3A-AD85-F785011BD3F1Q44737495-519E5837-23A2-4BC2-A3C3-8B2783B8BD2CQ49888000-8695889A-9559-41CE-8F6E-18E9D8E45842Q54949177-E7C4A29A-C093-4884-A5FF-0ED9F6B2032F
P2860
Activation of hepatocyte growth factor-met autocrine loop enhances tumorigenicity in a human lung adenocarcinoma cell line.
description
2000 nî lūn-bûn
@nan
2000 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Activation of hepatocyte growt ...... lung adenocarcinoma cell line.
@ast
Activation of hepatocyte growt ...... lung adenocarcinoma cell line.
@en
Activation of hepatocyte growt ...... lung adenocarcinoma cell line.
@nl
type
label
Activation of hepatocyte growt ...... lung adenocarcinoma cell line.
@ast
Activation of hepatocyte growt ...... lung adenocarcinoma cell line.
@en
Activation of hepatocyte growt ...... lung adenocarcinoma cell line.
@nl
prefLabel
Activation of hepatocyte growt ...... lung adenocarcinoma cell line.
@ast
Activation of hepatocyte growt ...... lung adenocarcinoma cell line.
@en
Activation of hepatocyte growt ...... lung adenocarcinoma cell line.
@nl
P2860
P356
P1433
P1476
Activation of hepatocyte growt ...... lung adenocarcinoma cell line
@en
P2860
P304
P356
10.1038/SJ.NEO.7900080
P577
2000-05-01T00:00:00Z